YiChang HEC ChangJiang Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 24 shareholders own 58.94% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
51.4%	Sunshine Lake Pharma Co., Ltd.	452,400,000	HK$5.9b	0%	no data
2.48%	Guangdong HEC Technology Holding Co., Ltd	21,815,200	HK$282.7m	0%	no data
1.79%	The Vanguard Group, Inc.	15,750,648	HK$204.1m	0.92%	no data
1.31%	Kit Mo	11,542,800	HK$149.6m	0%	no data
0.87%	Dimensional Fund Advisors LP	7,630,821	HK$98.9m	3.61%	no data
0.34%	Norges Bank Investment Management	2,988,191	HK$38.7m	-66.1%	no data
0.25%	BlackRock, Inc.	2,210,200	HK$28.6m	9.97%	no data
0.22%	GF Fund Management Co., Ltd.	1,931,000	HK$25.0m	0%	0.01%
0.084%	American Century Investment Management Inc	737,400	HK$9.6m	18.4%	no data
0.071%	State Street Global Advisors, Inc.	620,600	HK$8.0m	-6.23%	no data
0.027%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	234,400	HK$3.0m	-5.41%	no data
0.015%	Xinfa Tang	130,400	HK$1.7m	0%	no data
0.011%	Fullgoal Fund Management Co. Ltd.	100,000	HK$1.3m	0%	no data
0.0088%	Mandarine Gestion	77,400	HK$1.0m	0%	0.01%
0.0076%	Danjin Wang	67,200	HK$871.3k	0%	no data
0.0076%	Juncai Jiang	66,800	HK$865.6k	0%	no data
0.0076%	Shuang Li	66,800	HK$865.6k	0%	no data
0.0076%	Zhonghua Luo	66,800	HK$865.6k	0%	no data
0.0076%	Yangui Chen	66,400	HK$861.0k	0%	no data
0.0075%	Goldman Sachs Asset Management, L.P.	66,000	HK$855.3k	0%	no data
0.0054%	AXA Investment Managers S.A.	47,400	HK$614.7k	0%	no data
0.0049%	FinLABO SIM S.p.A., Asset Management Arm	43,000	HK$557.7k	0%	0.08%
0.0036%	Shengchao Wang	32,000	HK$415.1k	0%	no data
0.00045%	Xuechen Li	4,000	HK$51.3k	0%	no data